These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4110165)

  • 1. Hepatitis associated antigen: elimination from a dialysis unit and persistence in renal transplant recipients.
    Steiness I; Skinhoj P
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(6):721-5. PubMed ID: 4110165
    [No Abstract]   [Full Text] [Related]  

  • 2. Six-year survey of staff and patient hepatitis in a renal transplantation unit.
    Collste LG; Blomstrand R; Magnusson G
    Scand J Infect Dis; 1971; 3(2):113-9. PubMed ID: 4107948
    [No Abstract]   [Full Text] [Related]  

  • 3. Australia antigen in hemodialysis and renal transplantation units.
    Leski M; Grivaux C; Courouce-Pauty AM
    Vox Sang; 1970; 19(3):359-68. PubMed ID: 4993789
    [No Abstract]   [Full Text] [Related]  

  • 4. Presence and persistence of Australia antigen among drug addicts.
    Nordenfelt E; Kaij K; Ursing B
    Vox Sang; 1970; 19(3):371-8. PubMed ID: 4100647
    [No Abstract]   [Full Text] [Related]  

  • 5. Au antigen in at-risk patients.
    Kunst VA; Rosier JG
    Lancet; 1970 Feb; 1(7643):423-4. PubMed ID: 4189736
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemiology and prevention of "dialysis" hepatitis].
    Ermolenko VM; Vishnevskaia RK
    Ter Arkh; 1978; 50(6):134-44. PubMed ID: 79227
    [No Abstract]   [Full Text] [Related]  

  • 7. A hepatitis epidemic in a dialysis unit. Occurrence and persistence of Australia-antigen among patients and staff.
    Nordenfelt E; Lindholm T; Dahlquist E
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(6):692-700. PubMed ID: 5278889
    [No Abstract]   [Full Text] [Related]  

  • 8. [Can therapeutic measures cause a hepatitis virus infection to become chronic? (author's transl)].
    Müller R
    MMW Munch Med Wochenschr; 1976 May; 118(21):679-82. PubMed ID: 58376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of viral hepatitis.
    Kaboth U; Junge U
    Clin Gastroenterol; 1974 May; 3(2):453-70. PubMed ID: 4138500
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endemia of Australia (SH) antigen-positive hepatitis in a dialysis center].
    Kaboth U; Schober A; Klinge O; Lowitz HD; Quellhorst E; Scheler F; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Jul; 96(30):1235-42. PubMed ID: 4997734
    [No Abstract]   [Full Text] [Related]  

  • 11. Australia antigen in chronic hemodialysis.
    Andrassy K; Ritz E; Sanwald R
    Vox Sang; 1970; 19(3):369-70. PubMed ID: 4926157
    [No Abstract]   [Full Text] [Related]  

  • 12. Australia antigen and antibody in laboratory and other hospital personnel.
    Kunst VA; Bloo JH
    Vox Sang; 1973; 24():Suppl:61-4. PubMed ID: 4198172
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal transplantation in patients with Australia antigenemia.
    Reed W; Lucas ZJ; Kempson R; Cohn R
    Transplant Proc; 1971 Mar; 3(1):343-6. PubMed ID: 4937902
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Tolerating hepatitis.
    Grady G
    N Engl J Med; 1974 Jul; 291(2):96-7. PubMed ID: 4600117
    [No Abstract]   [Full Text] [Related]  

  • 15. Dialysis-associated hepatitis: prevention and control.
    Hawe BJ; Goldsmith HJ; Jones PO
    Br Med J; 1971 Mar; 1(5748):540-3. PubMed ID: 5547577
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of Australia antigen in patients after kidney transplantation].
    Müller R; Wonigeit K; Bahlmann J; Schmidt FW; Pichlmayr R; Ostertag H; Deicher H
    Klin Wochenschr; 1971 Jul; 49(13):768-9. PubMed ID: 4935072
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody against serum-hepatitis antigen. Prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections.
    Prince AM; Szmuness W; Woods KR; Grady GF
    N Engl J Med; 1971 Oct; 285(17):933-8. PubMed ID: 4106379
    [No Abstract]   [Full Text] [Related]  

  • 18. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of endemic HAA-positive hepatitis with gamma globulin. Use of a simple radioimmune assay to detect HAA.
    Ginsberg AL; Conrad ME; Bancroft WH; Ling CM; Overby LR
    N Engl J Med; 1972 Mar; 286(11):562-6. PubMed ID: 4110273
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of HAA-positive hepatitis with serum gamma globulin.
    Conrad ME
    N Engl J Med; 1971 Dec; 285(26):1486-7. PubMed ID: 4107820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.